To assess the ability of common genetic variants in aggregate to predict drug-induced QT
prolongation in patients being loaded with dofetilide or sotalol.
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Mayo Clinic The Cleveland Clinic University of Colorado, Denver VA Office of Research and Development